New South Wales (NSW) has a significant pharmaceutical and human therapeutic sector, with companies ranging from start-up to multinational. NSW is the base for 80% of the multinational pharmaceutical companies in Australia and 70% of pharmaceutical companies with regional headquarters.

Innovative biotechnology companies are basing their product development and services on recently evolved developments in biochemistry, genetics, molecular biology, immunology, cellular biology and other biological techniques.